2025 ASCLS, AGT & SAFMLS Joint Annual Meeting, June 8-12 in Sacramento, CA, or virtual. Register by April 8 and save.

2024 Clinical Laboratory Educators Conference (CLEC) February 22-24, Las Vegas, Virtual. Register by Dec 20 and save. 2024 Clinical Laboratory Educators Conference (CLEC) February 22-24, Las Vegas, Virtual. Register by Dec 20 and save.

News & Events

Society News Now

News Briefs

RSS ASCLS eNewsBytes

  • Study Explores Methods to Enhance Cancer-Gene Testing in Clinics March 10, 2025
    A study by Dr. Elizabeth Swisher and colleagues found that up to 10% of cancers are caused by genes easily detected by commercially available tests. The study suggests two ways primary-care practices could assess patients' hereditary cancer risks and deliver testing to those identified as higher risk.
  • FDA Approves New Combined Therapy for Relapsed or Refractory DLBCL March 10, 2025
    Adcetris®, a combination of lenalidomide and rituximab, has been approved by the FDA for treating relapsed or refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL), a common and difficult-to-treat form of lymphoma.
  • Immunotherapies Spark Excitement in Triple-Negative Breast Cancer Treatment March 10, 2025
    Immunotherapy approaches in triple-negative breast cancer have led to breakthroughs using immune checkpoint inhibitors. Researchers are exploring immunotherapy in combination with existing treatment modalities, such as pembrolizumab and SPARK.
  • FDA Approves Neffy 1 MG Nasal Spray for Pediatric Patients March 10, 2025
    The FDA has approved ARS Pharmaceuticals' neffy 1mg for treating Type 1 allergic reactions in pediatric patients aged four and above. Neffy is the first significant innovation for this population in over 35 years, addressing the concern of 56% of caregivers about injecting their child.
  • Could CRISPR Help Prevent the Next Global Pandemic? March 10, 2025
    CRISPR-CRISPR-associated systems, developed in bacteria, function as a microbial immune system to detect and defend against viral infections. They have been adapted for biomedical applications, including rapid pathogen detection and targeted gene modifications.

Calendar